Cargando…
Intranasal esketamine combined with oral midazolam provides adequate sedation for outpatient pediatric dental procedures: a prospective cohort study
Severe dental phobia or failure to cooperate with treatment are very common in outpatient pediatric dentistry. Personalized and appropriate noninvasive anesthesia methods can save medical expenses, improve treatment efficiency, reduce the anxiety of children, and improve the satisfaction of nursing...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10389564/ https://www.ncbi.nlm.nih.gov/pubmed/37288546 http://dx.doi.org/10.1097/JS9.0000000000000340 |
_version_ | 1785082328954961920 |
---|---|
author | Wang, Jing Zeng, Jie Zhao, Nan Chen, Silu Chen, Zhong Liao, Jingrong Ran, Haosong Yu, Cong |
author_facet | Wang, Jing Zeng, Jie Zhao, Nan Chen, Silu Chen, Zhong Liao, Jingrong Ran, Haosong Yu, Cong |
author_sort | Wang, Jing |
collection | PubMed |
description | Severe dental phobia or failure to cooperate with treatment are very common in outpatient pediatric dentistry. Personalized and appropriate noninvasive anesthesia methods can save medical expenses, improve treatment efficiency, reduce the anxiety of children, and improve the satisfaction of nursing staff. Currently, there is little conclusive evidence for noninvasive moderate sedation strategies in pediatric dental surgery. MATERIALS AND METHODS: The trial was conducted from May 2022 to September 2022. Each child was first given midazolam oral solution 0.5 mg·kg(−1), and when the Modified Observer’s Assessment of Alertness and Sedation score reached 4, a biased coin design up-down method was used to adjust the dose of esketamine. The primary outcome was the ED(95) and 95% CI of intranasal esketamine hydrochloride with midazolam 0.5 mg·kg(−1). Secondary outcomes included the onset time of sedation, treatment and awakening times, and the incidence of adverse events. RESULTS: A total of 60 children were enrolled; 53 children were successfully sedated but 7 were not. The ED(95) of intranasal esketamine with 0.5 mg·kg(−1) midazolam oral liquid for the treatment of dental caries was 1.99 mg·kg(−1) (95% CI 1.95–2.01 mg·kg(−1)). The mean onset time of sedation for all patients was 43.7±6.9 min. 15.0 (10–24.0) min for examination and 89.4±19.5 min for awakening. The incidence of intraoperative nausea and vomiting was 8.3%. Adverse reactions such as transient hypertension and tachycardia occurred during the operations. CONCLUSION: The ED(95) of intranasal esketamine with 0.5 mg·kg(−1) midazolam oral liquid for the outpatient pediatric dentistry procedure under moderate sedation was 1.99 mg·kg(−1). For children aged 2–6 years with dental anxiety who require dental surgery, anesthesiologists may consider using midazolam oral solution combined with esketamine nasal drops for noninvasive sedation after a preoperative anxiety scale evaluation. |
format | Online Article Text |
id | pubmed-10389564 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-103895642023-08-01 Intranasal esketamine combined with oral midazolam provides adequate sedation for outpatient pediatric dental procedures: a prospective cohort study Wang, Jing Zeng, Jie Zhao, Nan Chen, Silu Chen, Zhong Liao, Jingrong Ran, Haosong Yu, Cong Int J Surg Original Research Severe dental phobia or failure to cooperate with treatment are very common in outpatient pediatric dentistry. Personalized and appropriate noninvasive anesthesia methods can save medical expenses, improve treatment efficiency, reduce the anxiety of children, and improve the satisfaction of nursing staff. Currently, there is little conclusive evidence for noninvasive moderate sedation strategies in pediatric dental surgery. MATERIALS AND METHODS: The trial was conducted from May 2022 to September 2022. Each child was first given midazolam oral solution 0.5 mg·kg(−1), and when the Modified Observer’s Assessment of Alertness and Sedation score reached 4, a biased coin design up-down method was used to adjust the dose of esketamine. The primary outcome was the ED(95) and 95% CI of intranasal esketamine hydrochloride with midazolam 0.5 mg·kg(−1). Secondary outcomes included the onset time of sedation, treatment and awakening times, and the incidence of adverse events. RESULTS: A total of 60 children were enrolled; 53 children were successfully sedated but 7 were not. The ED(95) of intranasal esketamine with 0.5 mg·kg(−1) midazolam oral liquid for the treatment of dental caries was 1.99 mg·kg(−1) (95% CI 1.95–2.01 mg·kg(−1)). The mean onset time of sedation for all patients was 43.7±6.9 min. 15.0 (10–24.0) min for examination and 89.4±19.5 min for awakening. The incidence of intraoperative nausea and vomiting was 8.3%. Adverse reactions such as transient hypertension and tachycardia occurred during the operations. CONCLUSION: The ED(95) of intranasal esketamine with 0.5 mg·kg(−1) midazolam oral liquid for the outpatient pediatric dentistry procedure under moderate sedation was 1.99 mg·kg(−1). For children aged 2–6 years with dental anxiety who require dental surgery, anesthesiologists may consider using midazolam oral solution combined with esketamine nasal drops for noninvasive sedation after a preoperative anxiety scale evaluation. Lippincott Williams & Wilkins 2023-06-05 /pmc/articles/PMC10389564/ /pubmed/37288546 http://dx.doi.org/10.1097/JS9.0000000000000340 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-sa/4.0/This is an open access article distributed under the Creative Commons Attribution-ShareAlike License 4.0 (https://creativecommons.org/licenses/by-sa/4.0/) , which allows others to remix, tweak, and build upon the work, even for commercial purposes, as long as the author is credited and the new creations are licensed under the identical terms. http://creativecommons.org/licenses/by-sa/4.0/ (https://creativecommons.org/licenses/by-sa/4.0/) |
spellingShingle | Original Research Wang, Jing Zeng, Jie Zhao, Nan Chen, Silu Chen, Zhong Liao, Jingrong Ran, Haosong Yu, Cong Intranasal esketamine combined with oral midazolam provides adequate sedation for outpatient pediatric dental procedures: a prospective cohort study |
title | Intranasal esketamine combined with oral midazolam provides adequate sedation for outpatient pediatric dental procedures: a prospective cohort study |
title_full | Intranasal esketamine combined with oral midazolam provides adequate sedation for outpatient pediatric dental procedures: a prospective cohort study |
title_fullStr | Intranasal esketamine combined with oral midazolam provides adequate sedation for outpatient pediatric dental procedures: a prospective cohort study |
title_full_unstemmed | Intranasal esketamine combined with oral midazolam provides adequate sedation for outpatient pediatric dental procedures: a prospective cohort study |
title_short | Intranasal esketamine combined with oral midazolam provides adequate sedation for outpatient pediatric dental procedures: a prospective cohort study |
title_sort | intranasal esketamine combined with oral midazolam provides adequate sedation for outpatient pediatric dental procedures: a prospective cohort study |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10389564/ https://www.ncbi.nlm.nih.gov/pubmed/37288546 http://dx.doi.org/10.1097/JS9.0000000000000340 |
work_keys_str_mv | AT wangjing intranasalesketaminecombinedwithoralmidazolamprovidesadequatesedationforoutpatientpediatricdentalproceduresaprospectivecohortstudy AT zengjie intranasalesketaminecombinedwithoralmidazolamprovidesadequatesedationforoutpatientpediatricdentalproceduresaprospectivecohortstudy AT zhaonan intranasalesketaminecombinedwithoralmidazolamprovidesadequatesedationforoutpatientpediatricdentalproceduresaprospectivecohortstudy AT chensilu intranasalesketaminecombinedwithoralmidazolamprovidesadequatesedationforoutpatientpediatricdentalproceduresaprospectivecohortstudy AT chenzhong intranasalesketaminecombinedwithoralmidazolamprovidesadequatesedationforoutpatientpediatricdentalproceduresaprospectivecohortstudy AT liaojingrong intranasalesketaminecombinedwithoralmidazolamprovidesadequatesedationforoutpatientpediatricdentalproceduresaprospectivecohortstudy AT ranhaosong intranasalesketaminecombinedwithoralmidazolamprovidesadequatesedationforoutpatientpediatricdentalproceduresaprospectivecohortstudy AT yucong intranasalesketaminecombinedwithoralmidazolamprovidesadequatesedationforoutpatientpediatricdentalproceduresaprospectivecohortstudy |